MAP2K1 and systemic mastocytosis: MAP2K1 mutations can be observed in the whole spectrum of Spitz tumors, ranging from Spitz nevi (SN) to Spitz melanoma (SM) [65,66], while MAP2K1-activating in-frame deletions have been detected in Spitz melanocytomas with dense pigmentation and mostly indolent clinical course [65].